Pharmaceutical Firm Installs 9.95 MW Solar
KDC Solar commenced commercial operations of its 9.95- MW solar panel system in New Jersey. The system will provide electricity to Eli Lilly and Company’s ImClone biopharmaceutical operations in Branchburg, NJ.
The new system will generate nearly 12.9 million kWh per year. It will provide the primary Lilly manufacturing facility at this location with about 45 percent of its annual electricity needs. KDC Solar developed, owns and will operate the solar panel system.
KDC Solar signed an engineering and construction contract for the installation of the solar project with The Whiting-Turner Contracting Company and SPI Solar. Whiting-Turner was the general contractor, and SPI Solar provided solar panel procurement and oversight.
The solar panel system uses 40,180 PV panels, 16 Advanced Energy Industries 500 kilowatt inverters and is ground-mounted across 43 acres of land owned by a subsidiary of KDC Solar.
- Six Essential Steps to Drive Effective Energy Management
- Essential Guide to Lighting Retrofits and Upgrades
- Top 3 Reasons to Calculate Your Environmental Footprint
- Integrated Building Optimization
- Trends in Energy Management: Where Should Your Next Investment Be?
- The Guru’s Guide: Implementing Environmental ERP Systems
- Mobility From The Plant Floor To The Store Door: Improve Safety, Accuracy, and Productivity
- Integrating sustainability into your ERM framework
- Improve Your Company's Environment and Energy Performance
- 4 Reasons Operations Teams Can’t Live Without Real-Time Building Data
- Cut Costs and Improve Facility Operations with Energy Data
- Energy Procurement Strategies for Winter 2014 and 2015
- Energy Efficiency Requires Engineering Efficiency
- Integrated Building Optimization: A Crucial Convergence of Demand-side and Supply-Side Energy Management Strategies
- Driving Productivity and Profit with Industrial Energy Management